The value of human chorionic gonadotropin stimulation test in predicting ovarian response during in-vitro fertilization

[1]  O. Gonen,et al.  Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. , 2010, Human reproduction.

[2]  D. Dewailly,et al.  Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels. , 2010, Human reproduction.

[3]  L. Nardo,et al.  Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. , 2009, Fertility and sterility.

[4]  R. Casamitjana,et al.  Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  B. Leader,et al.  Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. , 2008, American journal of obstetrics and gynecology.

[6]  B. Mol,et al.  A systematic review of tests predicting ovarian reserve and IVF outcome. , 2006, Human reproduction update.

[7]  M. Bennett,et al.  Power doppler ultrasound assessment of the relationship between age and ovarian perifollicular blood flow in women undergoing in vitro fertilization treatment , 2006, Journal of Assisted Reproduction and Genetics.

[8]  R. Casamitjana,et al.  Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. , 2006, Human reproduction.

[9]  John L Frattarelli,et al.  Basal and cycle androgen levels correlate with in vitro fertilization stimulation parameters but do not predict pregnancy outcome. , 2006, Fertility and sterility.

[10]  C. Lambalk,et al.  The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization. , 2006, Fertility and sterility.

[11]  D. Barad,et al.  Increased oocyte production after treatment with dehydroepiandrosterone. , 2005, Fertility and sterility.

[12]  J. Habbema,et al.  Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. , 2005, Human reproduction.

[13]  F. Broekmans,et al.  Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF , 2005, Journal of Assisted Reproduction and Genetics.

[14]  S. Muttukrishna,et al.  Inhibin B and anti‐Mullerian hormone: markers of ovarian response in IVF/ICSI patients? , 2004, BJOG : an international journal of obstetrics and gynaecology.

[15]  W. Yeung,et al.  Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility. , 2004, Human reproduction.

[16]  J. Frattarelli,et al.  Effect of androgen levels on in vitro fertilization cycles. , 2004, Fertility and sterility.

[17]  Y. Hsieh,et al.  Clinical Assisted Reproduction: Antral Follicle Counting in Predicting the Retrieved Oocyte Number After Ovarian Hyperstimulation , 2001, Journal of Assisted Reproduction and Genetics.

[18]  J. Segars,et al.  A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. , 2003, Fertility and sterility.

[19]  A. Ruokonen,et al.  Ovarian age-related responsiveness to human chorionic gonadotropin. , 2003, The Journal of clinical endocrinology and metabolism.

[20]  D. Baird,et al.  Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. , 2003, Human reproduction.

[21]  F. Broekmans,et al.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. , 2002, Human reproduction.

[22]  G. Fried,et al.  Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment , 2002, Acta obstetricia et gynecologica Scandinavica.

[23]  J. Habbema,et al.  Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. , 2002, Fertility and sterility.

[24]  P. Serhal,et al.  Basal 17beta-estradiol did not correlate with ovarian response and in vitro fertilization treatment outcome. , 2000, Fertility and sterility.

[25]  R. Scott,et al.  Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. , 2000, Fertility and sterility.

[26]  光生 島田,et al.  肝切除における術前ステロイド投与の有用性 Randomized Prospective Study , 2000 .

[27]  W. Schoolcraft,et al.  Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. , 2000, Fertility and sterility.

[28]  P. Serhal,et al.  Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. , 1998, Fertility and sterility.

[29]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[30]  Y. Soong,et al.  Use of the antral follicle count to predict the outcome of assisted reproductive technologies. , 1998, Fertility and sterility.

[31]  S. Kahraman,et al.  Clomiphene citrate challenge test in the assessment of ovarian reserve before controlled ovarian hyperstimulation for intracytoplasmic sperm injection. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[32]  G. Lambert-Messerlian,et al.  Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. , 1997, Fertility and sterility.

[33]  R. Casamitjana,et al.  Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. , 1996, American journal of obstetrics and gynecology.

[34]  J. Hall,et al.  Prognostic value of day 3 estradiol on in vitro fertilization outcome. , 1995, Fertility and sterility.

[35]  R. Fanchin,et al.  Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. , 1994, Human reproduction.

[36]  S. Oehninger,et al.  The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle. , 1991, Fertility and sterility.

[37]  S. Muasher,et al.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. , 1991, Fertility and sterility.

[38]  T. Tanbo,et al.  Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in-vitro fertilization. , 1989, Human reproduction.

[39]  Z. Rosenwaks,et al.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. , 1989, Fertility and sterility.